T1	PROC 44 66	Estudio de la eficacia
T3	DISO 130 172	miocardiopatía hipertrófica no obstructiva
#2	AnnotatorNotes T3	C0340425; Hypertrophic cardiomyopathy without obstruction; Disease or Syndrome
T4	PROC 1599 1619	suspender el fármaco
#3	AnnotatorNotes T4	C0850893; stop medication; Therapeutic or Preventive Procedure
T5	PROC 195 243	Estudio multicéntrico, aleatorizado, doble ciego
T6	PROC 272 294	controlado con placebo
#4	AnnotatorNotes T6	C1706408; Placebo Control; Research Activity
T8	DISO 384 426	miocardiopatía hipertrófica no obstructiva
#6	AnnotatorNotes T8	C0340425; Hypertrophic cardiomyopathy without obstruction; Disease or Syndrome
T9	ANAT 941 961	Ventriculo Izquierdo
#7	AnnotatorNotes T9	C0225897; Left ventricular structure; Body Part, Organ, or Organ Component | C1269892; Entire left ventricle; Body Part, Organ, or Organ Component
T10	PROC 300 320	estudiar la eficacia
#8	AnnotatorNotes T10	C1707887; Efficacy Study; Research Activity
T11	DISO 428 446	MCH no obstructiva
#9	AnnotatorNotes T11	C0340425; Hypertrophic cardiomyopathy without obstruction; Disease or Syndrome
T12	DISO 471 513	miocardiopatía hipertrófica no obstructiva
#10	AnnotatorNotes T12	C0340425; Hypertrophic cardiomyopathy without obstruction; Disease or Syndrome
T13	ANAT 2413 2421	arterial
#11	AnnotatorNotes T13	C0003842; Arteries; Body Part, Organ, or Organ Component | C1285085; Entire artery; Body Part, Organ, or Organ Component
T14	DISO 519 536	afección genética
#12	AnnotatorNotes T14	C0019247; Hereditary Diseases; Disease or Syndrome
T15	ANAT 551 558	corazón
#13	AnnotatorNotes T15	C0018787; Heart; Body Part, Organ, or Organ Component | C1281570; Entire heart; Body Part, Organ, or Organ Component
T16	DISO 585 627	miocardiopatía hipertrófica no obstructiva
#14	AnnotatorNotes T16	C0340425; Hypertrophic cardiomyopathy without obstruction; Disease or Syndrome
T17	PROC 656 667	Diagnóstico
#15	AnnotatorNotes T17	C0011900; Diagnosis; Diagnostic Procedure
T18	DISO 671 698	miocardiopatía hipertrófica
#16	AnnotatorNotes T18	C0007194; Hypertrophic Cardiomyopathy; Disease or Syndrome
T19	ANAT 700 720	ventrículo izquierdo
#17	AnnotatorNotes T19	C0225897; Left ventricular structure; Body Part, Organ, or Organ Component | C1269892; Entire left ventricle; Body Part, Organ, or Organ Component
T20	DISO 700 734	ventrículo izquierdo hipertrofiado
#18	AnnotatorNotes T20	C0149721; Left Ventricular Hypertrophy; Disease or Syndrome
T21	ANAT 799 826	pared ventricular izquierda
#19	AnnotatorNotes T21	C0504053; Wall of left ventricle; Body Part, Organ, or Organ Component
T22	PROC 852 866	ecocardiograma
#20	AnnotatorNotes T22	C0013516; Echocardiography; Diagnostic Procedure
T23	PROC 916 961	Fracción de Eyección del Ventriculo Izquierdo
#21	AnnotatorNotes T23	C2700377; Measurement of Left Ventricular Ejection Fraction; Diagnostic Procedure
T24	PROC 987 1001	ecocardiograma
#22	AnnotatorNotes T24	C0013516; Echocardiography; Diagnostic Procedure
T25	DISO 1052 1060	Síntomas
#23	AnnotatorNotes T25	C1457887; Symptoms; Sign or Symptom
T26	DISO 1081 1103	insuficiencia cardíaca
#24	AnnotatorNotes T26	C0018801; Heart failure; Disease or Syndrome
T27	PROC 1166 1187	evaluación del médico
#25	AnnotatorNotes T27	C1444287; Physician status report assessment; Health Care Activity | C1444281; Physician contact assessment; Health Care Activity
T28	DISO 1201 1214	asintomáticos
#26	AnnotatorNotes T28	C0231221; Asymptomatic; Finding
T29	PROC 1241 1250	NT-proBNP
#27	AnnotatorNotes T29	C1533071; N terminal pro-brain natriuretic peptide level; Laboratory Procedure
T30	ANAT 1769 1775	septal
T31	PROC 1500 1523	métodos anticonceptivos
#28	AnnotatorNotes T31	C0700589; Contraceptive methods; Therapeutic or Preventive Procedure
T32	CHEM 1612 1619	fármaco
#29	AnnotatorNotes T32	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T33	PROC 963 967	FEVI
#30	AnnotatorNotes T33	C2114363; left ventricular ejection fraction assessment; Therapeutic or Preventive Procedure
T34	ANAT 1666 1707	tracto de salida del ventrículo izquierdo
#31	AnnotatorNotes T34	C0225912; Outflow tract of left ventricle; Body Part, Organ, or Organ Component
T35	PROC 1759 1775	reducción septal
T36	DISO 1857 1878	fibrilación auricular
#32	AnnotatorNotes T36	C0004238; Atrial Fibrillation; Disease or Syndrome
T37	PROC 1904 1925	prevención secundaria
#33	AnnotatorNotes T37	C0679699; Secondary Prevention; Therapeutic or Preventive Procedure
T38	PROC 1881 1898	colocación de ICD
#34	AnnotatorNotes T38	C2825184; Implantable Cardioverter-Defibrillator Placement; Therapeutic or Preventive Procedure
T39	PROC 1961 1994	prueba de esfuerzo cardiopulmonar
T40	ANAT 1980 1994	cardiopulmonar
#35	AnnotatorNotes T40	C0553534; Cardiopulmonary; Body Location or Region
T41	PROC 2092 2103	tratamiento
#36	AnnotatorNotes T41	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T42	CHEM 2108 2129	inhibidores de la ECA
#37	AnnotatorNotes T42	C0003015; Angiotensin-Converting Enzyme Inhibitors; Pharmacologic Substance
T43	CHEM 2191 2215	inhibidores de la renina
T44	CHEM 2593 2598	ARAII
#38	AnnotatorNotes T44	C0521942; Angiotensin II receptor antagonist; Pharmacologic Substance
T45	DISO 2219 2256	Trastorno infiltrativo o por depósito
T46	DISO 2262 2281	enfermedad de Fabry
#39	AnnotatorNotes T46	C0002986; Fabry Disease; Disease or Syndrome
T47	DISO 2285 2296	amiloidosis
#40	AnnotatorNotes T47	C0002726; Amyloidosis; Disease or Syndrome | C0011560; Amyloid deposition; Disease or Syndrom
T48	DISO 2299 2335	Enfermedades coronarias sintomáticas
T49	DISO 2375 2395	infarto de miocardio
#41	AnnotatorNotes T49	C0027051; Myocardial infarction; Disease or Syndrome | C0155626; Acute myocardial infarction; Disease or Syndrome
T50	DISO 2444 2467	hipotensión sintomática
#42	AnnotatorNotes T50	C0863113; Hypotension symptomatic; Pathologic Function
T51	PROC 2522 2533	tratamiento
#43	AnnotatorNotes T51	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T52	DISO 2618 2628	angioedema
#44	AnnotatorNotes T52	C0002994; Angioedema; Pathologic Function
T53	DISO 2632 2644	Hipertensión
#45	AnnotatorNotes T53	C0020538; Hypertensive disease; Disease or Syndrome
T54	PROC 2747 2756	protocolo
#46	AnnotatorNotes T54	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T55	CHEM 70 91	sacubitrilo/valsartán
#47	AnnotatorNotes T55	C4033631; sacubitril / valsartan; Pharmacologic Substance
T56	CHEM 324 345	sacubitrilo/valsartán
#48	AnnotatorNotes T56	C4033631; sacubitril / valsartan; Pharmacologic Substance
T57	ANAT 1095 1103	cardíaca
#49	AnnotatorNotes T57	C0018787; Heart; Body Part, Organ, or Organ Component | C1281570; Entire heart; Body Part, Organ, or Organ Component
T58	ANAT 1869 1878	auricular
#50	AnnotatorNotes T58	C0018792; Heart Atrium; Body Part, Organ, or Organ Component | C1280619; Entire atrium; Body Part, Organ, or Organ Component
T59	CHEM 2131 2180	antagonistas de los receptores de la angiotensina
#51	AnnotatorNotes T59	C0815017; Angiotensin Receptor Antagonists; Pharmacologic Substance
T60	CHEM 2182 2187	ARAII
#52	AnnotatorNotes T60	C0521942; Angiotensin II receptor antagonist; Pharmacologic Substance
T61	ANAT 2312 2322	coronarias
#53	AnnotatorNotes T61	C0205042; Coronary artery; Body Part, Organ, or Organ Component | C1269008; Entire coronary artery; Body Part, Organ, or Organ Component
T62	ANAT 2386 2395	miocardio
#54	AnnotatorNotes T62	C0027061; Myocardium; Tissue | C1284309; Entire myocardium; Tissue
T63	PROC 2405 2431	Presión arterial sistólica
#55	AnnotatorNotes T63	C1306620; Systolic blood pressure measurement; Diagnostic Procedure
T64	PROC 2575 2589	administración
#56	AnnotatorNotes T64	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T65	Date 12 16	2019
T66	Route 96 104	vía oral
#57	AnnotatorNotes T66	C1527415; Oral Route of Drug administration; Functional Concept
T67	LIVB 108 125	pacientes adultos
#58	AnnotatorNotes T67	C0030705; Patients; Patient or Disabled Group + C0001675; Adult; Age Group
T70	LIVB 245 253	paciente
#59	AnnotatorNotes T70	C0030705; Patients; Patient or Disabled Group
T71	LIVB 256 268	investigador
#60	AnnotatorNotes T71	C0035173; Research Personnel; Professional or Occupational Group
T72	Route 350 358	vía oral
#61	AnnotatorNotes T72	C1527415; Oral Route of Drug administration; Functional Concept
T73	LIVB 362 379	pacientes adultos
#62	AnnotatorNotes T73	C0030705; Patients; Patient or Disabled Group + C0001675; Adult; Age Group
T78	GENE 528 536	genética
#63	AnnotatorNotes T78	C0017337; Genes; Gene or Genome
T83	LIVB 1191 1200	pacientes
#64	AnnotatorNotes T83	C0030705; Patients; Patient or Disabled Group
T84	LIVB 1366 1388	Mujeres en edad fértil
#65	AnnotatorNotes T84	C4324275; Woman of childbearing potential; Population Group
T85	LIVB 1415 1422	mujeres
#66	AnnotatorNotes T85	C0043210; Woman; Population Group
T86	LIVB 1635 1644	Pacientes
#67	AnnotatorNotes T86	C0030705; Patients; Patient or Disabled Group
T87	Duration 1784 1795	los 3 meses
T88	LIVB 1929 1938	Pacientes
#68	AnnotatorNotes T88	C0030705; Patients; Patient or Disabled Group
T89	LIVB 2068 2077	Pacientes
#69	AnnotatorNotes T89	C0030705; Patients; Patient or Disabled Group
T90	Spec_cue 2348 2359	sospechadas
T94	PHYS 928 961	Eyección del Ventriculo Izquierdo
#70	AnnotatorNotes T94	C2733342; Left ventricular ejection; Physiologic Function
T95	PHYS 1458 1469	embarazadas
#71	AnnotatorNotes T95	C0033011; Pregnant Women; Population Group
T68	Duration 1578 1587	>/=7 días
T69	Age 1377 1388	edad fértil
T74	Date 2537 2549	preinclusión
T76	PROC 1126 1152	New York Heart Association
#72	AnnotatorNotes T76	C4706236; Assessment using New York Heart Association Classification; Health Care Activity
T77	PROC 1154 1158	NYHA
#73	AnnotatorNotes T77	C4706236; Assessment using New York Heart Association Classification; Health Care Activity
T79	PROC 1229 1233	NYHA
#74	AnnotatorNotes T79	C4706236; Assessment using New York Heart Association Classification; Health Care Activity
T75	DEVI 1895 1898	ICD
#75	AnnotatorNotes T75	C0162589; Implantable Cardioverter-Defibrillator; Medical Device
T80	LIVB 1181 1187	médico
#76	AnnotatorNotes T80	C0031831; Physicians; Professional or Occupational Group
T81	PROC 1280 1283	VO2
#77	AnnotatorNotes T81	C1305742; Oxygen consumption measurement; Diagnostic Procedure
T82	PROC 1946 1949	VO2
#78	AnnotatorNotes T82	C1305742; Oxygen consumption measurement; Diagnostic Procedure
T91	PROC 1812 1831	visita de selección
#79	AnnotatorNotes T91	C1710477; Trial Screening; Research Activity + C1512346; Patient Visit; Health Care Activity
T92	Quantifier_or_Qualifier 1832 1837	basal
A1	Population_data T67 Age
A2	Population_data T73 Age
A3	Assertion T48 Speculated
A4	Assertion T28 Negated
A5	Population_data T84 Age
A6	Status T35 History_of
A8	Status T36 History_of
A9	Status T38 History_of
A10	Status T48 History_of
A11	Status T49 History_of
A12	Assertion T64 Contraindicated
A13	Assertion T44 Contraindicated
A14	Status T52 History_of
#81	AnnotatorNotes T1	C1707887; Efficacy Study; Research Activity
#82	AnnotatorNotes T5	C1096776; Multicenter Study; Research Activity + C0034656; Randomization; Research Activity + C0013072; Double-Blind Method; Research Activity
#83	AnnotatorNotes T35	C3693513; septal reduction therapy; Therapeutic or Preventive Procedure 
#84	AnnotatorNotes T30	C0598032; septal area; Body Location or Region 
#85	AnnotatorNotes T39	C2959886; Cardiopulmonary Exercise Test; Diagnostic Procedure
#86	AnnotatorNotes T43	C3653375; Renin-inhibitors; Pharmacologic Substance 
T93	PROC 1812 1818	visita
#80	AnnotatorNotes T93	C1512346; Patient Visit; Health Care Activity
T96	Neg_cue 2645 2647	no
T97	Quantifier_or_Qualifier 2648 2658	controlada
A7	Assertion T97 Negated
T98	Observation 740 748	dilatado
A15	Assertion T98 Negated
#87	AnnotatorNotes T98	C0700124; Dilated; Finding
T99	Neg_cue 737 739	no
T100	Observation 161 172	obstructiva
A16	Assertion T100 Negated
T101	Neg_cue 158 160	no
T102	Neg_cue 432 434	no
T103	Neg_cue 412 414	no
T104	Observation 415 426	obstructiva
A17	Assertion T104 Negated
T105	Observation 435 446	obstructiva
A18	Assertion T105 Negated
T106	Neg_cue 499 501	no
T107	Observation 502 513	obstructiva
A19	Assertion T107 Negated
T108	Observation 616 627	obstructiva
A20	Assertion T108 Negated
T109	Neg_cue 613 615	no
T110	CONC 753 758	causa
A21	Assertion T110 Negated
#88	AnnotatorNotes T110	C0015127; Etiology aspects; Functional Concept | C1314792; Etiology; Functional Concept
T111	Neg_cue 749 752	sin
R1	Negation Arg1:T101 Arg2:T100	
R2	Negation Arg1:T103 Arg2:T104	
R3	Negation Arg1:T102 Arg2:T105	
R4	Negation Arg1:T106 Arg2:T107	
R5	Negation Arg1:T109 Arg2:T108	
R6	Negation Arg1:T99 Arg2:T98	
R7	Negation Arg1:T111 Arg2:T110	
R8	Speculation Arg1:T90 Arg2:T48	
R9	Negation Arg1:T96 Arg2:T97	
T112	Spec_cue 2671 2680	Se pueden
T113	Quantifier_or_Qualifier 2689 2694	otros
A22	Assertion T113 Speculated
T114	CONC 2695 2717	criterios de inclusión
A23	Assertion T114 Speculated
#89	AnnotatorNotes T114	C1512693; Inclusion Criteria; Qualitative Concept
R10	Has_Quantifier_or_Qualifier Arg1:T114 Arg2:T113	
R11	Speculation Arg1:T112 Arg2:T113	
R12	Speculation Arg1:T112 Arg2:T114	
T115	CONC 2720 2729	exclusión
A24	Assertion T115 Speculated
#90	AnnotatorNotes T115	C0680251; Exclusion Criteria; Functional Concept
R13	Speculation Arg1:T112 Arg2:T115	
R15	Has_Route_or_Mode Arg1:T55 Arg2:T66	
R16	Experiences Arg1:T67 Arg2:T55	
R18	Experiences Arg1:T67 Arg2:T3	
R20	Has_Route_or_Mode Arg1:T56 Arg2:T72	
R21	Experiences Arg1:T73 Arg2:T56	
R23	Experiences Arg1:T73 Arg2:T8	
R24	Experiences Arg1:T73 Arg2:T11	
R25	Experiences Arg1:T70 Arg2:T56	
R27	Experiences Arg1:T70 Arg2:T8	
R28	Experiences Arg1:T70 Arg2:T11	
R29	Location_of Arg1:T15 Arg2:T14	
R30	Location_of Arg1:T15 Arg2:T12	
R31	Location_of Arg1:T19 Arg2:T20	
R32	Location_of Arg1:T19 Arg2:T98	
T116	Quantifier_or_Qualifier 759 768	sistémica
A25	Assertion T116 Negated
#91	AnnotatorNotes T116	C0205373; Systemic; Functional Concept
R33	Has_Quantifier_or_Qualifier Arg1:T110 Arg2:T116	
R34	Negation Arg1:T111 Arg2:T116	
T117	Result_or_Value 830 839	>/= 13 mm
T118	Observation 786 826	grosor de la pared ventricular izquierda
#92	AnnotatorNotes T118	C2024242; cardiac evaluation of ventricular wall thickness; Finding (?)
R35	Has_Result_or_Value Arg1:T118 Arg2:T117	
R36	Location_of Arg1:T21 Arg2:T118	
T119	PROC 1033 1042	selección
#93	AnnotatorNotes T119	C0242802; Patient Selection; Research Activity
T120	PROC 898 907	selección
#94	AnnotatorNotes T120	C0242802; Patient Selection; Research Activity
R37	Overlap Arg1:T22 Arg2:T120	
R38	Overlap Arg1:T24 Arg2:T119	
T121	Quantifier_or_Qualifier 908 913	basal
#95	AnnotatorNotes T121	C1442488; Baseline; Quantitative Concept
T122	Quantifier_or_Qualifier 1043 1048	basal
#96	AnnotatorNotes T122	C1442488; Baseline; Quantitative Concept
T123	Result_or_Value 973 980	>/=50 %
R39	Has_Result_or_Value Arg1:T33 Arg2:T123	
R40	Has_Result_or_Value Arg1:T23 Arg2:T123	
R41	Location_of Arg1:T9 Arg2:T23	
R42	Location_of Arg1:T9 Arg2:T94	
R43	Overlap Arg1:T33 Arg2:T119	
R44	Overlap Arg1:T23 Arg2:T119	
R45	Causes Arg1:T26 Arg2:T25	
R46	Location_of Arg1:T57 Arg2:T26	
T124	Result_or_Value 1107 1119	clase II-III
R47	Has_Result_or_Value Arg1:T76 Arg2:T124	
R48	Has_Result_or_Value Arg1:T77 Arg2:T124	
R50	Experiences Arg1:T83 Arg2:T28	
R51	Experiences Arg1:T83 Arg2:T26	
R52	Experiences Arg1:T83 Arg2:T25	
T125	Result_or_Value 1215 1222	clase I
R53	Has_Result_or_Value Arg1:T79 Arg2:T125	
R54	Experiences Arg1:T83 Arg2:T77	
R55	Experiences Arg1:T83 Arg2:T76	
R56	Experiences Arg1:T83 Arg2:T79	
T126	Result_or_Value 1251 1274	por encima de 250 pg/ml
R57	Has_Result_or_Value Arg1:T29 Arg2:T126	
T127	Result_or_Value 1289 1312	<80 % del valor teórico
R58	Has_Result_or_Value Arg1:T81 Arg2:T127	
R59	Has_Age Arg1:T84 Arg2:T69	
R60	Experiences Arg1:T85 Arg2:T95	
R61	Has_Duration_or_Interval Arg1:T31 Arg2:T68	
R62	After Arg1:T31 Arg2:T4	
R63	Used_for Arg1:T32 Arg2:T4	
R64	Experiences Arg1:T84 Arg2:T31	
R65	Experiences Arg1:T84 Arg2:T4	
R66	Experiences Arg1:T85 Arg2:T31	
R67	Experiences Arg1:T84 Arg2:T95	
R68	Experiences Arg1:T85 Arg2:T4	
T128	PROC 1652 1707	gradiente del tracto de salida del ventrículo izquierdo
T129	Result_or_Value 1731 1739	>30 mmHg
R69	Has_Result_or_Value Arg1:T128 Arg2:T129	
T130	Quantifier_or_Qualifier 1708 1717	en reposo
R70	Has_Quantifier_or_Qualifier Arg1:T128 Arg2:T130	
T131	Quantifier_or_Qualifier 1720 1730	provocable
R71	Has_Quantifier_or_Qualifier Arg1:T128 Arg2:T131	
R73	Location_of Arg1:T30 Arg2:T35	
R74	Overlap Arg1:T35 Arg2:T87	
R75	Before Arg1:T35 Arg2:T91	
R76	Has_Quantifier_or_Qualifier Arg1:T93 Arg2:T92	
R77	Before Arg1:T35 Arg2:T93	
R78	Location_of Arg1:T58 Arg2:T36	
R79	Used_for Arg1:T75 Arg2:T38	
R80	Experiences Arg1:T88 Arg2:T82	
T132	Observation 1280 1288	VO2 pico
T133	Observation 1946 1954	VO2 pico
R83	Location_of Arg1:T40 Arg2:T39	
R84	Experiences Arg1:T88 Arg2:T39	
T134	Result_or_Value 2017 2040	>80 % del valor teórico
R85	Has_Result_or_Value Arg1:T82 Arg2:T134	
T135	PROC 2001 2010	selección
#97	AnnotatorNotes T135	C1710477; Trial Screening; Research Activity 
R86	Overlap Arg1:T39 Arg2:T135	
#98	AnnotatorNotes T92	C1442488; Baseline; Quantitative Concept
T136	Quantifier_or_Qualifier 2011 2016	basal
#99	AnnotatorNotes T136	C1442488; Baseline; Quantitative Concept
R88	Experiences Arg1:T89 Arg2:T41	
R89	Used_for Arg1:T42 Arg2:T41	
R90	Used_for Arg1:T59 Arg2:T41	
R91	Used_for Arg1:T60 Arg2:T41	
R92	Used_for Arg1:T43 Arg2:T41	
R93	Location_of Arg1:T61 Arg2:T48	
R94	Location_of Arg1:T13 Arg2:T63	
T137	Result_or_Value 2432 2441	<100 mmHg
R95	Has_Result_or_Value Arg1:T63 Arg2:T137	
T138	PROC 2490 2499	selección
#100	AnnotatorNotes T138	C1710477; Trial Screening; Research Activity
T139	Quantifier_or_Qualifier 2500 2505	basal
#101	AnnotatorNotes T139	C1442488; Baseline; Quantitative Concept
R96	Overlap Arg1:T50 Arg2:T138	
R97	Overlap Arg1:T63 Arg2:T138	
R98	Overlap Arg1:T51 Arg2:T74	
R99	Overlap Arg1:T63 Arg2:T51	
R100	Overlap Arg1:T50 Arg2:T51	
R101	Used_for Arg1:T44 Arg2:T64	
R102	Has_Quantifier_or_Qualifier Arg1:T53 Arg2:T97	
T140	Quantifier_or_Qualifier 2659 2670	persistente
#102	AnnotatorNotes T140	C0205322; Persistent; Temporal Concept
R103	Has_Quantifier_or_Qualifier Arg1:T53 Arg2:T140	
R104	Overlap Arg1:T118 Arg2:T120	
R105	Has_Quantifier_or_Qualifier Arg1:T22 Arg2:T121	
R106	Has_Quantifier_or_Qualifier Arg1:T24 Arg2:T122	
T141	Quantifier_or_Qualifier 1524 1543	altamente efectivos
R107	Has_Quantifier_or_Qualifier Arg1:T31 Arg2:T141	
R108	Has_Quantifier_or_Qualifier Arg1:T39 Arg2:T136	
R109	Has_Quantifier_or_Qualifier Arg1:T50 Arg2:T139	
#1	AnnotatorNotes T130	C0443144; At rest; Functional Concept
R14	Location_of Arg1:T62 Arg2:T49	
R17	Has_Quantifier_or_Qualifier Arg1:T63 Arg2:T139	
R19	Has_Quantifier_or_Qualifier Arg1:T8 Arg2:T104	
R22	Has_Quantifier_or_Qualifier Arg1:T11 Arg2:T105	
R26	Has_Quantifier_or_Qualifier Arg1:T12 Arg2:T107	
R49	Has_Quantifier_or_Qualifier Arg1:T16 Arg2:T108	
R72	Location_of Arg1:T19 Arg2:T18	
R87	Location_of Arg1:T21 Arg2:T20	
R110	Location_of Arg1:T21 Arg2:T18	
#5	AnnotatorNotes T132	C4727347; Peak Oxygen Consumption; Finding
R81	Has_Result_or_Value Arg1:T132 Arg2:T127	
R111	Has_Age Arg1:T85 Arg2:T69	
R112	Location_of Arg1:T34 Arg2:T128	
R113	Location_of Arg1:T58 Arg2:T38	
#103	AnnotatorNotes T133	C4727347; Peak Oxygen Consumption; Finding
R82	Location_of Arg1:T61 Arg2:T49	
R114	Location_of Arg1:T13 Arg2:T50	
R115	Has_Quantifier_or_Qualifier Arg1:T3 Arg2:T100	
R116	Overlap Arg1:T33 Arg2:T24	
R117	Overlap Arg1:T23 Arg2:T24	
R118	Experiences Arg1:T86 Arg2:T128	
#104	AnnotatorNotes T128	C2022577; echocardiography: left ventricular outflow tract; Diagnostic Procedure(?)
#105	AnnotatorNotes T100	C0028778; Obstruction; Finding
#106	AnnotatorNotes T105	C0028778; Obstruction; Finding
#107	AnnotatorNotes T104	C0028778; Obstruction; Finding
#108	AnnotatorNotes T107	C0028778; Obstruction; Finding
#109	AnnotatorNotes T108	C0028778; Obstruction; Finding
R120	Overlap Arg1:T20 Arg2:T98	
R122	Overlap Arg1:T18 Arg2:T118	
R121	Overlap Arg1:T18 Arg2:T120	
R119	Has_Quantifier_or_Qualifier Arg1:T115 Arg2:T113	
#110	AnnotatorNotes T113	C0205394; Other; Qualitative Concept
A26	Experiencer T67 Patient
A27	Experiencer T70 Patient
A28	Experiencer T71 Other
A29	Experiencer T73 Patient
A30	Experiencer T80 Other
A31	Experiencer T83 Patient
A32	Experiencer T84 Patient
A33	Experiencer T85 Patient
A34	Experiencer T86 Patient
A35	Experiencer T88 Patient
A36	Experiencer T89 Patient
A37	Assertion T31 Hypothetical
A38	Assertion T141 Hypothetical
A39	Assertion T68 Hypothetical
A40	Assertion T4 Hypothetical
A41	Assertion T32 Hypothetical
